-
FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
Tuesday, April 13, 2021 - 3:08pm | 856Read More...The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine. In a joint audio press conference hosted by Acting FDA Commissioner Janet Woodcock,...
-
Benzinga's Bulls And Bears Of The Week: Apple, Chevron, GM, GE, Peloton And More
Saturday, April 10, 2021 - 12:05pm | 1320Read More...Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the iPhone maker, Google's parent and an automotive leader. Financial and energy giants and COVID-19 vaccine makers were among the bearish calls seen during the...
-
Fed Minutes Later Today Loom Large As Investors Seek Insight Into FOMC's Next Steps
Wednesday, April 7, 2021 - 10:49am | 2381Read More...It’s been a dull week so far, but things pick up starting today in case you’re falling asleep. The main event comes this afternoon with minutes from the last Federal Open Market Committee (FOMC) meeting last month. The minutes are being looked at as something that could give the market...
-
Is Silicon Valley Replacing Big Pharma In Neuroscience?
Tuesday, April 6, 2021 - 8:54am | 1311Read More...The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Over the past decade, big pharma has largely stepped away from the...
-
Intel Helps Market Comeback As Shares Rise Following Announcement
Wednesday, March 24, 2021 - 9:58am | 1883Read More...Like spring weather, the stock market can be fickle. After yesterday’s blustery headwinds of coronavirus worry, this morning is pointing to a calmer day as stocks look to recover some ground. It seems like some end-of-quarter rebalancing activity may be behind some of the volatility, but...
-
Wednesday's Market Minute: Bulls Are Losing Their Touch
Wednesday, March 24, 2021 - 9:49am | 662Read More...The powerful rotation trade that’s been raging since September finally hit a speed bump this past week thanks to anxiety around Europe’s reliance on the AstraZeneca plc (NASDAQ: AZN) vaccine and some hiccups in the reopening here at home. Crude oil’s faceplant upon passing the $60...
-
Nasdaq Has Strong Overnight Session, Led By Tesla, As Yields Step Back
Monday, March 22, 2021 - 9:53am | 2091Read More...After a bumpy finish Friday, the road feels smoother as we start the final full week of Q1. This easy cruising might not last, however, with another appearance from Fed Chairman Jerome Powell on tap tomorrow. Some positive vaccine news and a dip in Treasury yields provided early support,...
-
Fintech Focus For March 16, 2021
Monday, March 15, 2021 - 5:56pm | 1966Read More...Quote To Start The Day: “When someone tells me something can’t be done, I think there’s always a will and a way.” Source: Randall Kaplan One Big Thing In Fintech: One driving force behind innovation is disruption. That’s according to Allison Beer, the Chief Product...
-
Barron's Latest Picks And Pans: COVID Booster Shot Plays, Defense M&As, Coty, Hologic, And More
Sunday, February 14, 2021 - 8:47am | 1123Read More...This weekend's Barron's cover story offers a look at the 100 must sustainable companies. Other featured articles discuss the changing vaccine industry, the history of electric vehicles and consolidation in the defense sector. Also, the prospects for a medical-diagnostics company, a high-...
-
'The Third Wave': Stock Market Update For The Week Ahead
Sunday, December 6, 2020 - 7:15pm | 1183Read More...The Past Week, In A Nutshell What Happened: In light of hopes for a sustained economic rebound, U.S. broad market indices pushed to new all-time highs. Remember This: “[T]he third wave is now hitting the economy harder than we thought and that the damage is likely to keep adding up in coming...
-
World's Biggest Vaccine Producer Lends Support to AstraZeneca After Drugmaker Misstep
Saturday, November 28, 2020 - 5:28pm | 492Read More...Serum Institute of India (SII), which has partnered with Novavax, Inc (NASDAQ: NVAX) and AstraZeneca Plc (NYSE: AZN) for trials in India, believes the latter’s COVID-19 vaccine is “a very good one.” What Happened: SII Chief Executive Adar Poonawalla praised the efficiency of...
-
Benzinga's Bulls And Bears Of The Week: AstraZeneca, Disney, Ford, GE, Roku And More
Saturday, November 28, 2020 - 1:06pm | 1228Read More...AstraZeneca HQ and research center in Cambridge, United Kingdom Benzinga has examined the prospects or many investor favorite stocks over the past week. The bullish calls in the holiday-shortened week included old-school and newer consumer favorites. A COVID-19 vaccine contender and a casino...
-
Reinventing Vaccines To Save Lives And The Economy
Tuesday, November 24, 2020 - 12:45pm | 1205Read More...Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus vaccine candidate. Moderna Inc (NASDAQ: MRNA) had its turn last week delivering even better news with U.S. stocks hitting a new record. This Monday,...
-
Barron's Picks And Pans: Alibaba, Intel, Target, Visa And More
Saturday, November 14, 2020 - 4:07pm | 1039Read More...This weekend's Barron's cover offers a low-risk strategy for investors optimistic about an ecomomic recovery. Other featured articles discuss what a COVID-19 vaccine would mean for the stock market and how it could shake up the pharmaceutical industry. Also, the prospects for semiconductor...
-
Barron's Picks And Pans: AT&T, GE, Zynga And More
Sunday, November 1, 2020 - 10:56am | 1151Read More...This weekend's Barron's examines why the merger frenzy among chipmakers has not impressed investors. Other featured articles discuss stock picks for any presidential outcome, how health insurers perform after elections, and the good, bad and odd of big tech earnings. Also, the...
